Apolipoprotein E ε4 homozygosity exacerbates retinal and cerebral microvascular dysfunction in Alzheimer's disease: A mediation analysis of vascular contributions to cognitive decline
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.71000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Yuntao Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoprotein E4, Cognitive Dysfunction, Retinal Vessels. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, Zhejiang Clinovation Pride Code, National Key Research and Development Program of China.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for Alzheimer's disease (AD), with homozygous carriers (ε4/ε4) experiencing accelerated cognitive decline. While its role in amyloid and tau pathology is established, its impact on retinal and cerebral microvasculature remains underexplored. METHODS A total of 107 AD (46 non‐carriers, 42 heterozygotes, 19 homozygotes) underwent optical coherence tomography angiography (OCTA) to assess retinal microvasculature and magnetic resonance imaging (MRI) ‐derived peak width of skeletonized mean diffusivity (PSMD) to evaluate cerebral small vessel disease. Plasma biomarkers (Aβ 42 , p‐tau217, glial fibrillary acidic protein [GFAP], neurofilament light chain [NfL]) and cognitive scores were also analyzed. RESULTS Homozygous APOE ε4 carriers exhibited the most severe reduction in retinal microvascular density and higher PSMD ( p < 0.001). Superficial retinal vessels and PSMD partially mediated APOE ε4's association with cognitive impairment. DISCUSSION APOE ε4 homozygosity exacerbates retinal and cerebral microvascular dysfunction, which partially mediates cognitive impairment in AD. Highlights Apolipoprotein E (APOE) ε4 homozygosity is associated with the most severe reductions in retinal microvascular densities and elevated cerebral small vessel disease (peak width of skeletonized mean diffusivity [PSMD]) in Alzheimer's disease (AD). Vascular dysfunction (retinal and cerebral) correlates with lower Aβ42, higher p‐tau217/Aβ 42 , and worse cognitive scores (Mini‐Mental State Examination [MMSE], Montreal Cognitive Assessment [MoCA]). Mediation analysis reveals that retinal (superficial vascular complex [SVC]) and cerebral (PSMD) microvascular changes partially explain the link between APOE ε4 and cognitive decline. Findings highlight vascular pathways as potential therapeutic targets in APOE ε4 carriers to mitigate cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Neurology, Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
- Department of Geriatrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Nanjing Vazyme Biotech Company Limited, Nanjing, Qixia, China.
- Gerald Choa Neuroscience Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.
Förderung
- National Key R&D Program of China
- Zhejiang Clinovation Pride Code
- National Key Research and Development Program of China
Zitieren
APA
Liu, Y., Zhu, H., Wang, Y., Luan, X., Chen, J., Qian, J., Shen, J., Liu, Y., Wen, C., Cao, L., Tang, B., Ko, H., Kwapong, W. R., & Wang, Z. (2025). Apolipoprotein E ε4 homozygosity exacerbates retinal and cerebral microvascular dysfunction in Alzheimer's disease: A mediation analysis of vascular contributions to cognitive decline. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71000
Vancouver
Liu Y, Zhu H, Wang Y, Luan X, Chen J, Qian J, et al. Apolipoprotein E ε4 homozygosity exacerbates retinal and cerebral microvascular dysfunction in Alzheimer's disease: A mediation analysis of vascular contributions to cognitive decline. Alzheimer's & Dementia. 2025. doi:10.1002/alz.71000
BibTeX
@article{Liu2025,
author = {Liu, Yuntao and Zhu, Hanyu and Wang, Youjie and Luan, Xiaoqian and Chen, Jiahui and Qian, Jiajing and Shen, Jianing and Liu, Yinhe and Wen, Caiyun and Cao, Lin and Tang, Bo and Ko, Ho and Kwapong, William Robert and Wang, Zhen},
title = {Apolipoprotein E ε4 homozygosity exacerbates retinal and cerebral microvascular dysfunction in Alzheimer's disease: A mediation analysis of vascular contributions to cognitive decline},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.71000}
}
EUVIMED